453 related articles for article (PubMed ID: 34691077)
1. Partners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis.
Toren E; Burnette KS; Banerjee RR; Hunter CS; Tse HM
Front Immunol; 2021; 12():756548. PubMed ID: 34691077
[TBL] [Abstract][Full Text] [Related]
2. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
Christen U; Kimmel R
Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
[TBL] [Abstract][Full Text] [Related]
3. The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes.
Tai N; Wong FS; Wen L
J Autoimmun; 2016 Jul; 71():26-34. PubMed ID: 27021275
[TBL] [Abstract][Full Text] [Related]
4. The case for an autoimmune aetiology of type 1 diabetes.
Mannering SI; Pathiraja V; Kay TW
Clin Exp Immunol; 2016 Jan; 183(1):8-15. PubMed ID: 26313217
[TBL] [Abstract][Full Text] [Related]
5. Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes.
Marré ML; Profozich JL; Coneybeer JT; Geng X; Bertera S; Ford MJ; Trucco M; Piganelli JD
J Autoimmun; 2016 Aug; 72():33-46. PubMed ID: 27173406
[TBL] [Abstract][Full Text] [Related]
6. Bioengineering strategies for inducing tolerance in autoimmune diabetes.
Baekkeskov S; Hubbell JA; Phelps EA
Adv Drug Deliv Rev; 2017 May; 114():256-265. PubMed ID: 28625830
[TBL] [Abstract][Full Text] [Related]
7. Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets.
Rodriguez-Calvo T; Johnson JD; Overbergh L; Dunne JL
Front Immunol; 2021; 12():667989. PubMed ID: 33953728
[TBL] [Abstract][Full Text] [Related]
8. Type 1 diabetes mellitus: much progress, many opportunities.
Powers AC
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33759815
[TBL] [Abstract][Full Text] [Related]
9. Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.
Hampe CS
Autoimmunity; 2012 Jun; 45(4):320-31. PubMed ID: 22288464
[TBL] [Abstract][Full Text] [Related]
10. An accomplice more than a mere victim: The impact of β-cell ER stress on type 1 diabetes pathogenesis.
Sahin GS; Lee H; Engin F
Mol Metab; 2021 Dec; 54():101365. PubMed ID: 34728341
[TBL] [Abstract][Full Text] [Related]
11. Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes.
Pietropaolo M; Towns R; Eisenbarth GS
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028135
[TBL] [Abstract][Full Text] [Related]
12. Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes.
Li CR; Baaten BJ; Bradley LM
J Mol Cell Biol; 2012 Feb; 4(1):38-47. PubMed ID: 22116888
[TBL] [Abstract][Full Text] [Related]
13. Type I interferons as key players in pancreatic β-cell dysfunction in type 1 diabetes.
Marroqui L; Perez-Serna AA; Babiloni-Chust I; Dos Santos RS
Int Rev Cell Mol Biol; 2021; 359():1-80. PubMed ID: 33832648
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic islet reserve in type 1 diabetes.
Flatt AJS; Greenbaum CJ; Shaw JAM; Rickels MR
Ann N Y Acad Sci; 2021 Jul; 1495(1):40-54. PubMed ID: 33550589
[TBL] [Abstract][Full Text] [Related]
15. Immune mechanisms in type 1 diabetes.
Wållberg M; Cooke A
Trends Immunol; 2013 Dec; 34(12):583-91. PubMed ID: 24054837
[TBL] [Abstract][Full Text] [Related]
16. The immunology of type 1 diabetes.
Herold KC; Delong T; Perdigoto AL; Biru N; Brusko TM; Walker LSK
Nat Rev Immunol; 2024 Jun; 24(6):435-451. PubMed ID: 38308004
[TBL] [Abstract][Full Text] [Related]
17. Disease-modifying immunotherapy for the management of autoimmune diabetes.
Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
[TBL] [Abstract][Full Text] [Related]
19. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans.
Serreze DV; Niens M; Kulik J; DiLorenzo TP
Methods Mol Biol; 2016; 1438():137-51. PubMed ID: 27150089
[TBL] [Abstract][Full Text] [Related]
20. Inherent Beta Cell Dysfunction Contributes to Autoimmune Susceptibility.
Kim YK; Sussel L; Davidson HW
Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33808310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
